Skip to main navigation
logo
  • About
    • Company
    • Leadership
    • Laboratory
    • Careers
  • Products
    • IMMUNO-/PRECISION ONCOLOGY
      • Immuno ID NeXT PlatformTM
      • NeXT PersonalTM
      • NeXT Liquid BiopsyTM
    • ONCOLOGY CLINICAL DIAGNOSTICS
      • NeXT Dx TestTM
    • PHARMA RESEARCH SOLUTIONS
      • Exome Sequencing
      • Transcriptome Sequencing
      • Whole Genome Sequencing
      • Targeted Cancer Panels
      • miRNA Sequencing
  • Applications
    • Biomarker Discovery
    • Personalized Therapeutics
    • Population Genomics
  • Technology
    • Our Processes
    • Unlock the power of DNA
    • Optimizing RNA
    • NeoantigenID
    • MHC binding prediction
    • ImmunogenomicsID
    • Reliable delivery
  • Resources
    • News Center
    • Conferences
    • Library
    • Blog
    • Contact
  • Investors
    • Overview
    • Press Releases
    • Events
    • SEC Filings
    • Stock Information
    • Corporate Governance
    • Analyst Coverage
    • Investor FAQs
    • Investor Contacts
    • Email Alerts

Events Details

Q1 2020 Personalis Earnings Conference Call

May 7, 2020 at 5:00 PM EDT

Click here for webcast
Print Page
RSS Feeds
Email Alerts
Contact IR
Corporate Website
© 2023 Personalis Inc. All rights reserved.
logo